Canada Approves its Third Drug For Amyotrophic Lateral Sclerosis (ALS)
Thanks to Amylyx Pharmaceuticals, Canada becomes the first country worldwide to have access to an ALS drug branded Albrioza (originally AMX0035). According to an article in Yahoo News, the drug…